Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

News

  1. Home>
  2. News>
  3. News>
  4. Page 13

Indian Pharma Exports Rise 6.6%: Nifty Pharma Hits Record High in 2026

  • Post published:July 4, 2026
  • Post category:News

India's pharmaceutical sector has entered the second half of 2026 on a strong footing, with exports rising 6.6% year-on-year and the Nifty Pharma index hitting an all-time high in early…

Continue Reading Indian Pharma Exports Rise 6.6%: Nifty Pharma Hits Record High in 2026

India Pharma Mid-2026: FDA Filings Lead China, API Prices Drop, Biosimilars Rise

  • Post published:July 2, 2026
  • Post category:News

India's pharmaceutical sector continues to strengthen its global position with a series of positive developments in mid-2026. From extending its lead over China in US FDA drug master filings to…

Continue Reading India Pharma Mid-2026: FDA Filings Lead China, API Prices Drop, Biosimilars Rise

US-India Trade Deal Very Close: Indian Generics Sector Gains Edge

  • Post published:June 29, 2026
  • Post category:News

The long-anticipated US-India bilateral trade deal is moving toward finalization, with major implications for India's generic pharmaceutical industry. US President Donald Trump confirmed at the G7 summit in Évian, France…

Continue Reading US-India Trade Deal Very Close: Indian Generics Sector Gains Edge

India Pharma 2026: CDSCO Fast-Track Trials, Biosimilar Guidelines, and Innovation Agenda

  • Post published:June 27, 2026
  • Post category:News

The Indian pharmaceutical sector is undergoing a significant transformation in 2026, driven by landmark regulatory reforms from the Central Drugs Standard Control Organization (CDSCO), new clinical trial fast-track rules, updated…

Continue Reading India Pharma 2026: CDSCO Fast-Track Trials, Biosimilar Guidelines, and Innovation Agenda
  • Go to the previous page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 20
  • Go to the next page

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
    November 16, 2026/
    0 Comments
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
    November 15, 2026/
    0 Comments
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
    November 14, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
  • How to Read a CDSCO Clinical Trial Approval: A 2026 Buyer’s Guide
  • India’s Phytopharmaceutical Rules: 4-Marker Standard for Herbals

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve